Abstract
Although there is considerable interest in the role of neutrophils and platelets in acute cerebral ischemiareperfusion, there are very little data related to the effect of systemic thrombolytic therapy on these blood elements. In the present study a rabbit model was used to examine the effects of cerebral ischemia, tissue-plasminogen activator therapy, or both on neutrophil and platelet peripheral counts and activity, the latter studied by stimulated neutrophil and platelet impedance aggregation and neutrophil oxygen-free radical chemiluminescence. New Zealand white rabbits (n=25) were randomized to receive either tissue-plasminogen activator (6.3 mg/kg IV; 20% bolus, remainder as a 2-hour infusion) or vehicle (0.9% saline) 3 hours following either autologous clot embolization or sham carotid artery isolation. Thus, four groups were examined: sham (n=4), tPA only (n=4), stroke only (n=8), and stroke plus tPA (n=9). Two hours after completion of thrombolytic therapy or vehicle infusion, the experiments were terminated, that is, 7 hours following autologous clot embolization or sham instrumentation. Blood was sampled from the thoracic aorta, and neutrophil and platelet peripheral counts and activity were determined prior to embolization and 0.5, 2.0, 4.0, and 7.0 hours following autologous clot embolization. No significant difference in platelet counts, either over time or between groups, was noted. In contrast to the platelet counts, the neutrophil count significantly increased over time, rising approximately 2.5-fold from baseline in all four groups (p<0.001). No significant increase in neutrophil accumulation (myeloperoxidase assay; 107 PMNs/g tissue; mean ± SEM) was noted within infarcted regions of either the stroke (1.26±0.07; n=5) or stroke plus tissue-plasminogen activator (1.26±0.09; n=5) groups when compared to either viable brain regions within the ischemic hemisphere (1.29±0.03; n=4) or in sham controls (1.36±0.35; n=4). Neutrophil activity (aggregation, oxygen-free radical release) in both groups undergoing autologous clot embolization demonstrated a trend toward higher values when compared to the two sham-operated groups. Tissue-plasminogen activator administration did not significantly affect ex vivo neutrophil activity. In contrast, platelet aggregation was significantly reduced by the administration of tPA with (p=0.001) or without (p<0.01) autologous clot embolization. Thus, in the present rabbit model platelet but not neutrophil activity is modulated by the administration of tissue-plasminogen activator, while autologous clot embolization results in a trend toward acute neutrophil activation.
Similar content being viewed by others
References
Wardlaw JM, Warlow CP. Thrombolysis in acute ischemic stroke: Does it work?Stroke 1992;23:1826–1839.
Levine SR, Brott TG. Thrombolytic therapy in cerebrovascular disorders.Prog Cardiovasc Dis 1992;34:235–262.
Welbourn CRB, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB. Pathophysiology of ischemia reperfusion injury: Central role of the neutrophil.Br J Surg 1991;78:651–655.
Shiga Y, Onodera H, Kogure K, et al. Neutrophil as a mediator of ischemic edema formation in the brain.Neurosci Lett 1991;125:110–112.
del Zoppo GJ, Schmid-Schönbein GW, More E, Copeland BR, Change C-M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons.Stroke 1991;22:1276–1283.
Bednar MM, Raymond S, McAuliffe T, Lodge PA, Gross CE. The role of neutrophils and platelets in a rabbit model of thromboembolic stroke.Stroke 1991;22:44–50.
Grøgaard B, Scührer L, Gerdin B, Arfors KE. Delayed hypoperfusion after incomplete forebrain ischemia in the rat. The role of polymorphonuclear leukocytes.J Cereb Blood Flow Metab 1989;9:500–505.
Kohut JJ, Bednar MM, Kimelberg JK, McAuliffe TL, Gross CE. Reduction in ischemic brain injury by the anion transport inhibitor L644,711.Stroke 1992;23:93–97.
Turcani P, Gotch F, Ishihara N, Tanaka K, Gomi S, Takashima S, Mihara. Were platelets involved in the pathogenesis of ischemic brain edema in gerbils?Stroke 1988;19:486–489.
Smith III EF, Nichols AJ, Sellers TS, et al. Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinase.J Cardiovasc Pharmacacol 1991;18:729–738.
Ranjadayalan K, Umachandran V, Davies SW, Syndercombe-Court D, Gutteridge CN, Timmis AD. Thrombolytic treatment in acute myocardial infarction: Neutrophil activation, peripheral leucocyte response, and myocardial injury.Br Heart J 1991;66:10–14.
Mehta JL, Mehta P, Lawson DL, Herzbrun L. Tissue plasminogen activator and plasmin independently decrease human neutrophil activation.Life Sci 1989;45:1665–1669.
Ryan TJ, Lai L, Malik AB. Plasmin generation induces neutrophil aggregation: Dependence on the catalytic and lysine binding sites.J Cell Physiol 1992;151:255–261.
Bertolino G, Noris P, Previtali M, Gamba G, Ferrario M, Montani N, Balduini CL. Platelet function after in vivo and in vitro treatment with thrombolytic agents.Am J Cardiol 1992;69:457–461.
Montrucchio G, Alloatti G, Mariano F, et al. Role of plateletactivating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.Circ Res 1993;72:658–670.
Penny WF, Ware JA. Platelet activation and subsequent inhibition of plasmin and recombinant tissue-type plasminogen activator.Blood 1992;79:91–98.
Kerins DM, Roy L, FitzGerald GA, Fitzgerald DJ. Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator.Circulation 1989;80:1718–1725.
Rao GHR, Wilson RF, White CW, White JG. Influence of thrombolytic agents on human platelet function.Thromb Res 1991;62:319–334.
Bednar MM, McAuliffe T, Raymond S, Gross EC. Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke.Stroke 1990;21:1705–1709.
Wilson JT, Bednar MM, McAuliffe TL, Raymond S, Gross CE. The effect of 21-aminosteroid U74006F in a rabbit model of thromboembolic stroke.Neurosurgery 1992;31:929–934.
Gross CE, Bednar MM, Howard DB, Sporn MB. Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model.Stroke 1993;24:558–562.
Young W. Hydrogen clearance measurement of blood flow. A review of technique and polarographic principles.Stroke 1980;11:552–564.
Jones TH, Morawetz RB, Crowell RM, Marcous FW, Fitzgibbin SJ, DeGirolami U, Ojemann RG. Thresholds of focal cerebral ischemia in awake monkeys.J Neurosurg 1981;54:773–782.
Bednar MM, Raymond SJ, Gross CE. Tissue plasminogen activator: Comparison of dose and route of administration in a rabbit model of thromboembolic stroke.Neurol Res 1993;15:405–408.
Thomas GR, Thibodeaux H, Bennett WF, Refino CJ, Badillo JM, Errett CH, Zivin JA. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.J Pharm Exp Ther 1993;264:67–73.
Barone FC, Hillegass LM, Price WJ, et al. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification.J Neurosci Res 1991;29:336–345.
Russell-Smith NC, Flower RJ, Cardinal DC. Measuring platelet and leukocyte aggregation/adhesion responses in very small volumes of whole blood.J Pharmacol Methods 1981;6:315–333.
Nagahata H, Dezzutti CS, Kociba GJ. A rapid microassay for measuring the luminol-dependent chemiluminescent response in canine whole blood.Vet Immunol Immunopathol 1991;29:285–293.
Uchiyama S, Yamazaki M, Maruyama S. Role of plateletactivating factor in aggregation of leukocytes and platelets in cerebral ischemia.Lipids 1991;26:1247–1249.
Violi F, Rasura M, Alessandri C, et al. Leukocyte response in patients suffering from acute stroke.Stroke 1988;19:1283–1284.
Galante A, Pietroiusti A, Silvestrini M, Stanzione P, Bernardi G. Leukocyte aggregation: A possible link between infection and ischemic stroke.Stroke 1992;23:1533.
Grau AJ, Berger E, Sung K-LP, Schmid-Schönbein GW. Granulocyte adhesion, deformability, and superoxide formation in acute stroke.Stroke 1992;23:33–39.
Tohgi H, Suzuki H, Tamura K, Kinura B. Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis.Stroke 1991;22:17–21.
Shah AB, Beamer N, Coull BM. Enhanced in vivo platelet activation in subtypes of ischemic stroke.Stroke 1985;16:643–647.
Nicolini FA, Wilson AC, Mehta P, Mehta JL. Comparative platelet inhibitory effects of human neutrophils and lymphocytes.J Lab Clin Med 1990;116:147–152.
Fears R, Ferres H, Greenwood HC. Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin.Thromb Res 1990;60:259–268.
Niewiarowski S, Senyi AF, Gillies P. Plasmin-induced platelet aggregation and platelet release reaction: Effects on hemostasis.J Clin Invest 1973;52:1647–1659.
Ohlstein EH, Storer B, Fujita T, Shebuski RJ. Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit.Thromb Res 1987;46:575–585.
Barone FC, Schmidt DB, Hillegass LM, et al. Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia.Stroke 1992;23:1337–1348.
Garcia JH. The evolution of brain infarcts. A review.J Neuropathol Exp Neurol 1992;51:387–393.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bednar, M.M., Dooley, R.H., Zamani, M. et al. Neutrophil and platelet activity and quantification following delayed tPA therapy in a rabbit model of thromboembolic stroke. J Thromb Thrombol 1, 179–185 (1995). https://doi.org/10.1007/BF01062576
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01062576